John Hamm

7.7k citations
77 papers · 5.4k · 2 hit papers · h-index 23

Impact in

  • Oncology top 0.5%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Cancer Cells and Metastasis
    • Cancer Genomics and Diagnostics

Papers in

    • Lung Cancer Research Studies 10
    • Cancer Treatment and Pharmacology 9
    • Cancer Immunotherapy and Biomarkers 7
    • CAR-T cell therapy research 7
    • Colorectal Cancer Treatments and Studies 6
    • Pancreatic and Hepatic Oncology Research 6
    • Lung Cancer Treatments and Mutations 9

John Hamm

73 papers receiving 5.2k citations

John Hamm's Hit Papers

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group 2007 · 3.0k citations
3.0k0+7+14Years since publication10002.0k3.0k

Peers

John Hamm
Comparison fields: 5 of 119
  • Oncology 3.5k
  • Cancer Research 994
  • Pulmonary and Respiratory Medicine 1.1k
  • Hepatology 199
  • Biotechnology 187
Replace Thomas Brunner with:
Thomas Brunner Germany
Mark M. Zalupski United States
Andrea Wang‐Gillam United States
Evaristo Maiello Italy
Syed A. Ahmad United States
Shoji Natsugoe Japan
Roger von Moos Switzerland
Hans G. Beger Germany
Young Suk Park South Korea
Thierry Conroy France
John Hamm relative to Thomas Brunner Germany Thomas Brunner's profile →
Citations per field
00.5×1.7×
Thomas Brunner · 1×
Citations per year

Countries citing papers authored by John Hamm

Since Specialization
Citations

This map shows the geographic impact of John Hamm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hamm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hamm more than expected).

Fields of papers citing papers by John Hamm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hamm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hamm. The network helps show where John Hamm may publish in the future.

Co-authors

The 25 scholars most cited alongside John Hamm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Hamm Line = papers co-authored together John Hamm links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
Hit paper breakdown →
20073002
2
Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial
Hit paper breakdown →
2005743
3 2003311
4 2022109
5 2013106
6 199198
7 200476
8 200970
9 201362
10 201248
11 202048
12 199447
13 202145
14 202341
15 198340
16 201338
17 201236
18 201935
19 201834
20 201131

About John Hamm

John Hamm is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Cancer Research, having authored 77 papers that have together received 5.4k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (10 papers), Cancer Treatment and Pharmacology (9 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Oncology (3.5k citations), Cancer Research (994 citations), Pulmonary and Respiratory Medicine (1.1k citations), Hepatology (199 citations) and Biotechnology (187 citations). John Hamm has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include J. Randolph Hecht, P. Murawa, Robert Lim, Arié Figer, Keyue Ding, Robert A. Wolff, Gary M. Clark, Malcolm J. Moore, Daniel de Castro and David Goldstein. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Breast Cancer Research and Treatment, Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact